Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
Background/Aims Although rituximab, an antiCD20 monoclonal antibody, has dramatically improved the clinical outcomes of diffuse large B-cell lymphoma, rituximab resistance remains a challenge. Methods We developed a rituximab-resistant cell line (RRCL) by sequential exposure to gradually increasing...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Association of Internal Medicine
2023-11-01
|
| Series: | The Korean Journal of Internal Medicine |
| Subjects: | |
| Online Access: | http://www.kjim.org/upload/kjim-2023-134.pdf |